151 related articles for article (PubMed ID: 7798296)
21. Regulation of GTP biosynthesis.
Weber G; Nakamura H; Natsumeda Y; Szekeres T; Nagai M
Adv Enzyme Regul; 1992; 32():57-69. PubMed ID: 1353938
[TBL] [Abstract][Full Text] [Related]
22. Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid, on glycoprotein metabolism.
Sokoloski JA; Sartorelli AC
Mol Pharmacol; 1985 Dec; 28(6):567-73. PubMed ID: 2867464
[TBL] [Abstract][Full Text] [Related]
23. Differentiation and reduction of intracellular GTP levels in HL-60 and U937 cells upon treatment with IMP dehydrogenase inhibitors.
Inai K; Tsutani H; Yamauchi T; Nakamura T; Ueda T
Adv Exp Med Biol; 1998; 431():549-53. PubMed ID: 9598126
[No Abstract] [Full Text] [Related]
24. The expression of the myc proto-oncogene in a dimethylsulfoxide resistant HL-60 cell line.
Grosso LE; Pitot HC
Cancer Lett; 1984 Feb; 22(1):55-63. PubMed ID: 6583000
[TBL] [Abstract][Full Text] [Related]
25. Inosine 5'-monophosphate dehydrogenase inhibition by mycophenolic acid impairs maturation and function of dendritic cells.
Dubsky PC; Friedl J; Stift A; Bachleitner-Hofmann T; Jakesz R; Gnant MF; Weigel G
Clin Chim Acta; 2006 Feb; 364(1-2):139-47. PubMed ID: 16051207
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the effects of mizoribine with those of azathioprine, 6-mercaptopurine, and mycophenolic acid on T lymphocyte proliferation and purine ribonucleotide metabolism.
Dayton JS; Turka LA; Thompson CB; Mitchell BS
Mol Pharmacol; 1992 Apr; 41(4):671-6. PubMed ID: 1569921
[TBL] [Abstract][Full Text] [Related]
27. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W
Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
[TBL] [Abstract][Full Text] [Related]
28. Evidence for a relationship between intracellular GTP levels and the induction of HL-60 leukemia cell differentiation by 5,10-dideazatetrahydrofolic acid (DDATHF).
Sokoloski JA; Pizzorno G; Beardsley GP; Sartorelli AC
Oncol Res; 1993; 5(8):293-9. PubMed ID: 8012061
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast growth factor-dependent metabolism of hypoxanthine via the salvage pathway for purine synthesis in porcine aortic endothelial cells.
Hirai S; Hayashi Y; Koizumi T; Nakanishi N; Fukui T; Ichikawa A
Biochem Pharmacol; 1993 Apr; 45(8):1695-701. PubMed ID: 7683470
[TBL] [Abstract][Full Text] [Related]
30. Profiles of purine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
Katahira R; Ashihara H
Planta; 2006 Dec; 225(1):115-26. PubMed ID: 16845529
[TBL] [Abstract][Full Text] [Related]
31. Differentiation inducing effects of butyrate and DMSO on human intestinal tumor cell lines in culture.
Joshi SS; Jackson JD; Sharp JG
Cancer Detect Prev; 1985; 8(1-2):237-45. PubMed ID: 4064044
[TBL] [Abstract][Full Text] [Related]
32. Characterization of mutant murine lymphoma cells with altered inosinate dehydrogenase activities.
Ullman B
J Biol Chem; 1983 Jan; 258(1):523-8. PubMed ID: 6129253
[TBL] [Abstract][Full Text] [Related]
33. Characterization of purine nucleotide metabolism in primary rat muscle cultures.
Zoref-Shani E; Shainberg A; Sperling O
Biochim Biophys Acta; 1982 Jun; 716(3):324-30. PubMed ID: 6180773
[TBL] [Abstract][Full Text] [Related]
34. Induction of erythroid differentiation in K562 cells by inhibitors of inosine monophosphate dehydrogenase.
Yu J; Lemas V; Page T; Connor JD; Yu AL
Cancer Res; 1989 Oct; 49(20):5555-60. PubMed ID: 2571408
[TBL] [Abstract][Full Text] [Related]
35. Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5'-phosphate dehydrogenase.
Sokoloski JA; Blair OC; Sartorelli AC
Cancer Res; 1986 May; 46(5):2314-9. PubMed ID: 2870796
[TBL] [Abstract][Full Text] [Related]
36. Differentiation-inducing agents decrease cryptic prolactin receptors in cultured rat mammary tumor cells.
Costlow ME
Exp Cell Res; 1984 Nov; 155(1):17-23. PubMed ID: 6092117
[TBL] [Abstract][Full Text] [Related]
37. Cell differentiation and altered IMP dehydrogenase expression induced in human T-lymphoblastoid leukemia cells by mycophenolic acid and tiazofurin.
Kiguchi K; Collart FR; Henning-Chubb C; Huberman E
Exp Cell Res; 1990 Mar; 187(1):47-53. PubMed ID: 1967583
[TBL] [Abstract][Full Text] [Related]
38. Inosine-5'-monophosphate dehydrogenase is required for mitogenic competence of transformed pancreatic beta cells.
Metz S; Holland S; Johnson L; Espling E; Rabaglia M; Segu V; Brockenbrough JS; Tran PO
Endocrinology; 2001 Jan; 142(1):193-204. PubMed ID: 11145582
[TBL] [Abstract][Full Text] [Related]
39. Modulation of secreted plasminogen activator activity of human renal carcinoma cells by dimethylsulfoxide, butyrate and retinoate.
Nelson NF; Cieplak W; Dacus SC; Prager MD
Cancer Lett; 1987 Mar; 34(3):305-16. PubMed ID: 3548947
[TBL] [Abstract][Full Text] [Related]
40. Alterations of inosinate branchpoint enzymes in cultured human lymphoblasts.
Gruber HE; Jansen I; Willis RC; Seegmiller JE
Biochim Biophys Acta; 1985 Jul; 846(1):135-44. PubMed ID: 2861860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
